MedPath

Efficacy of Infliximab as a second Bio in patients with refractory rheumatoid arthritis

Not Applicable
Conditions
Rheumatoid arthritis
Registration Number
JPRN-UMIN000020799
Lead Sponsor
Hokkaido University Hospital, Medicine II
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

contraindication of infliximab and methotorexate pregnant women nursing women

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath